How Monocytes Contribute to Increased Risk of Atherosclerosis in Virologically-Suppressed HIV-Positive Individuals Receiving Combination Antiretroviral Therapy-Reference-Cited by-同舟云学术

How Monocytes Contribute to Increased Risk of Atherosclerosis in Virologically-Suppressed HIV-Positive Individuals Receiving Combination Antiretroviral Therapy

Published:2019-06-19 Issue: Volume:10 Page:
ISSN:1664-3224
Container-title:Frontiers in Immunology
language:
Short-container-title:Front. Immunol.

Author:

Jaworowski Anthony,Hearps Anna C.,Angelovich Thomas A.,Hoy Jennifer F.

Funder

National Health and Medical Research Council

Publisher

Frontiers Media SA

Subject

Immunology,Immunology and Allergy

Reference145 articles.

1. Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trial;Grinsztejn;Lancet Infect Dis.,2014

2. Narrowing the gap in life expectancy between HIV-infected and HIV-uninfected individuals with access to care;Marcus;J Acquir Immune Defic Syndr.,2016

3. Early treatment of primary HIV infection is associated with decreased mortality;Pinto;AIDS Res Hum Retroviruses.,2018

4. Limiting cumulative HIV viremia copy-years by early treatment reduces risk of AIDS and death;Olson;J Acquir Immune Defic Syndr.,2016

5. Long-term survival in HIV positive patients with up to 15 Years of antiretroviral therapy;McManus;PLoS ONE.,2012

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A secondary abdominal aorta-duodenal fistula accompanied with acquired Immune Deficiency Syndrome presented with recurrent sepsis: a case report;BMC Infectious Diseases;2024-07-04

2. Comparison of Integrase Strand Transfer Inhibitors (INSTIs) and Protease-Boosted Inhibitors (PIs) on the Reduction in Chronic Immune Activation in a Virally Suppressed, Mainly Male Population Living with HIV (PLWH);Medicina;2024-02-15

3. Injecting drug use and hepatitis C virus infection independently increase biomarkers of inflammatory disease risk which are incompletely restored by curative direct-acting antiviral therapy;Frontiers in Immunology;2024-02-14

4. Alterations in Th17 Cells and Non-Classical Monocytes as a Signature of Subclinical Coronary Artery Atherosclerosis during ART-Treated HIV-1 Infection;Cells;2024-01-15

5. A Blood Immunological Signature of Subclinical Coronary Artery Atherosclerosis in People Living with HIV-1 Receiving Antiretroviral Therapy;2023-12-18